Phase I study with weekly Paclitaxel (1 H) infusion in heavily pretreated advanced breast cancer and ovarian cancer patients

被引：0
|
作者：
Klaassen, U [1 ]
Wilke, H [1 ]
Strumberg, D [1 ]
Eberhardt, W [1 ]
Korn, M [1 ]
Seeber, S [1 ]
机构：
[1] UNIV ESSEN GESAMTHSCH,W GERMAN CANC CTR,DEPT INTERNAL MED CANC RES,ESSEN,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：380 / 380
页数：1
相关论文
共 50 条
  • [1] Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer
    Klaassen, U
    Wilke, H
    Strumberg, D
    Eberhardt, W
    Korn, M
    Seeber, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (03) : 547 - 549
  • [2] The effect of single weekly paclitaxel in heavily pretreated patients with recurrent or persistent advanced ovarian cancer
    Kita, T
    Kikuchi, Y
    Takano, M
    Suzuki, M
    Oowada, M
    Konno, R
    Yamamoto, K
    Inoue, H
    Seto, H
    Yamamoto, T
    Shimizu, K
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 813 - 818
  • [3] Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients
    Yamamoto, K
    Oogi, S
    Inoue, H
    Kudoh, K
    Kita, T
    Kikuchi, Y
    [J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (04) : 425 - 428
  • [4] Phase I study of weekly docetaxel (Taxotere(R)) in heavily pretreated breast cancer patients
    Luck, HJ
    Donne, S
    Glaubitz, M
    Kuhnle, H
    Marhenke, P
    Welker, T
    Dreps, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 703 - 703
  • [5] Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study
    Stathopoulos, GP
    Rigatos, SK
    Christodoulou, C
    Malamos, NA
    Deliyiannis, F
    Stathopoulos, JG
    Skarlos, DV
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (03) : 259 - 264
  • [6] Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study
    George P. Stathopoulos
    Sotiris K. Rigatos
    Christos Christodoulou
    Nikos A. Malamos
    Filippos Deliyiannis
    John G. Stathopoulos
    Dimosthenis V. Skarlos
    [J]. Cancer Chemotherapy and Pharmacology, 2004, 54 : 259 - 264
  • [7] A Phase II Feasibility Study of Weekly Paclitaxel in Heavily Pretreated Advanced Gastric Cancer Patients with Poor Performance Status
    Im, Chong Kun
    Rha, Sun Young
    Jeung, Hei-Cheul
    Jeong, Jaeheon
    Lee, Soo Hyeon
    Noh, Sung Hoon
    Roh, Jae Kyung
    Chung, Hyun Cheol
    [J]. ONCOLOGY, 2009, 77 (06) : 349 - 357
  • [8] Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes
    Blum, Joanne L.
    Savin, Michael A.
    Edelman, Gerald
    Pippen, John E.
    Robert, Nicholas J.
    Geister, Brian V.
    Kirby, Robert L.
    Clawson, Alicia
    O'Shaughnessy, Joyce A.
    [J]. CLINICAL BREAST CANCER, 2007, 7 (11) : 850 - 856
  • [9] Weekly paclitaxel and 5-fluorouracil in pretreated patients with metastatic breast cancer: A phase I study
    Cortesi, E
    Grifalchi, F
    Ramponi, S
    Padovani, A
    Mancuso, A
    Paoluzzi, L
    Ferrau, F
    Oliva, A
    [J]. ANTICANCER RESEARCH, 2003, 23 (2C) : 1961 - 1966
  • [10] THE EFFECT OF SINGLE WEEKLY PACLITAXEL IN HEAVILY PRETREATED OVARIAN CANCER PATIENTS AND ITS ANTIANGIOGENIC EFFECTS
    Kikuchi, Yoshihiro
    Kita, Tsunekazu
    Takano, Masashi
    Kudoh, Kazuya
    Saito, Keiko
    Fujii, Kazuyuki
    Sasaki, Naoki
    [J]. ANTICANCER RESEARCH, 2004, 24 (5D) : 3535 - 3535
12345